Our firm handles a variety of cases. Included below are many of our ongoing or notable complex litigation cases. Please visit our Areas of Practice page to read more about the types of cases we handle, or contact us for additional information.
On June 27, 2018, a jury in the United States District Court for the District of Colorado returned a verdict in favor of plaintiffs in three consolidated cases against DaVita, Inc. (“DaVita”) in the amount of $8.5 million in compensatory damages and $375 million in punitive damages for the three plaintiffs. Read more.
On September 18, 2015, the U.S. Environmental Protection Agency announced findings that Volkswagen had installed software on diesel cars that enabled them to cheat on emissions tests. Numerous civil and criminal actions and investigations were launched as a result, and three class action settlements have occurred to-date; however, some VW owners have been excluded from those settlements. Read more.
Levaquin (levofloxacin) is an antibiotic that is part of a class of antibiotics known as fluoroquinolones. Other antibiotics in this class include Cipro (ciprofloxacin), Avelox (moxifloxacin), Noroxin (norfloxacin), Floxin (ofloxacin), and Factive (gemifloxacin). In July 2008, the FDA added a Box Warned for these antibiotics due to the increased risk of tendinitis and tendon rupture. In 2013, the FDA began requiring drug labels and Medication Guides to better describe another crippling side effect: peripheral neuropathy (nerve damage). Read more.
Paynter Law filed multiple class-action lawsuits involving Meracord, LLC (formerly NoteWorld, LLC), a major player in the for-profit debt relief industry. Multiple lawsuits were filed by consumers against Meracord and related entities alleging that Meracord conspired, along with scores—if not hundreds—of “front-end” debt relief companies, to defraud indebted consumers by falsely representing their services, the fees they would charge, and other important facts. A Washington Court certified a Class in the action and awarded damages, and the Class then pursued recovery against two insurance companies that issued bonds on Meracord’s behalf. Read more.
Paynter Law has filed a class-action lawsuit against Valeant Pharmaceuticals International Inc. (“Valeant”) alleging anticompetitive actions and antitrust violations related to Valeant’s recently acquired monopoly over the market for certain specialty contact lens materials. Read more.
NCAA Player Likeness
The In re NCAA Student-Athlete Name & Likeness Licensing Litigation began with Paynter Law and Hagens Berman filing suit against the NCAA, Electronic Arts, and the Collegiate Licensing Company, alleging that those entities had unlawfully used the names and likenesses of NCAA student athletes in sports videogames distributed by Electronic Arts.
After five years of litigation, the Class of student-athletes reached a $60 million combined settlement with the NCAA and Electronic Arts. For more information on that settlement, visit www.ncaa-ea-likeness-settlement.com.